Umar S. Boston, MD, Steven P. Goldberg, MD, Kent E. Ward, MD, Edward D

Slides:

Advertisements

Similar presentations

Max B. Mitchell, MD The Journal of Thoracic and Cardiovascular Surgery

Advertisements

Of mice and men and surgical transcatheter aortic valve insertion

Can papillary muscle interventions improve mitral valve repair durability for ischemic mitral regurgitation? Christos G. Mihos, DO, Orlando Santana,

Valve-sparing aortic root replacement and remodeling with complex aortic valve reconstruction in children and young adults with moderate or severe aortic.

Mitral stenosis with pulmonary hypertension: We should operate early

Outcomes of neonatal Ebstein's anomaly without right ventricular forward flow Jae Suk Baek, MD, Jeong Jin Yu, MD, Yu Mi Im, PhD, Tae-Jin Yun, MD, PhD

When is the Ross operation a good option to treat aortic valve disease? Tirone E. David, MD, Anna Woo, MD, Susan Armstrong, MSc, Manjula Maganti, MSc

Mild-to-moderate functional tricuspid regurgitation in patients undergoing mitral valve surgery Sun Kyun Ro, MD, Joon Bum Kim, MD, Sung Ho Jung, MD,

Pulmonary hypertension in valve disease: A beast of the past?

Marc R. Moon, MD The Journal of Thoracic and Cardiovascular Surgery

Form ever follows function

A new approach: Ischemic mitral regurgitation guidelines by and for surgeons Patrick M. McCarthy, MD The Journal of Thoracic and Cardiovascular Surgery

Functional mitral stenosis after mitral valve repair is a true anatomic problem that originates from the time of surgery Vincent Chan, MD, MPH, Thierry.

Harold L. Lazar, MD The Journal of Thoracic and Cardiovascular Surgery

Biventricular root replacement for transcatheter pulmonary valve endocarditis after Ross operation: Double the trouble T.K. Susheel Kumar, MD, Kaitlin.

Long-term results of aortic valve–sparing operations in patients with Marfan syndrome Tirone E. David, MD, Sue Armstrong, BSc, Manjula Maganti, BSc, Jack.

Early repair of hemitruncus: Excellent early and late outcomes

Application of Cone Reconstruction for Neonatal Ebstein Anomaly or Tricuspid Valve Dysplasia Masanori Mizuno, MD, PhD, Takaya Hoashi, MD, PhD, Heima.

Christopher J. Knott-Craig, MD, Steven P. Goldberg, MD, Edward D

Mitral valve repair with the new semirigid partial Colvin–Galloway Future annuloplasty band Ruediger Lange, MD, Thomas Guenther, MD, Birgit Kiefer, MD,

The variability of the mitral valve anatomy and terminology

Does the degree of preoperative mitral regurgitation predict survival or the need for mitral valve repair or replacement in patients with anomalous origin.

A near 100% repair rate for mitral valve prolapse is achievable in a reference center: Implications for future guidelines Javier G. Castillo, MD, Anelechi.

Pharmacotherapy for closure of large patent ductus arteriosus in preterm neonates: Fail once, not twice Stephanie L. Perrier, MD, Igor E. Konstantinov,

The role of cognitive dissonance in the management of functional tricuspid regurgitation at the time of degenerative mitral valve repair Rakesh M. Suri,

The assessment of cost effectiveness and the effectiveness of cost assessment in cardiothoracic surgery Vinay Badhwar, MD The Journal of Thoracic and.

It's not “just a shunt” but sometimes it should be…

Get it right the first time

Tricuspid regurgitation or Ebsteinoid dysplasia of the tricuspid valve in congenitally corrected transposition: Is valvuloplasty necessary at anatomic.

Surgery for aortic and mitral valve disease in the United States: A trend of change in surgical practice between 1998 and 2005 Scott D. Barnett, PhD,

The Journal of Thoracic and Cardiovascular Surgery

The Journal of Thoracic and Cardiovascular Surgery

Tirone E. David, MD, Gheorghe Gavra, MD, Christopher M

Fenton H. McCarthy, MD, MS, Nimesh D. Desai, MD, PhD

Chin L. Poh, BMedSci, Mary Xu, BMedSci, John C

Replicating the success of mitral valve repair in the aortic valve

Surgical management of pulmonary artery sling in children

Increased risk of dehiscence after tricuspid valve repair with rigid annuloplasty rings Bettina Pfannmüller, MD, Torsten Doenst, MD, PHD, Katja Eberhardt,

Pre-dicting post-ligation syndrome

Commentary: Ongoing advancements in the understanding of tricuspid valve dynamics and functional geometry Daniel J.P. Burns, MD, MPhil The Journal of.

Commentary: Do the right thing! Ethical versus legal

Passing the torch The Journal of Thoracic and Cardiovascular Surgery

How much is enough to warrant prophylactic tricuspid repair?

Who is your plastic surgeon

Shunt right or left? Decision 2016

Functional tricuspid pathology: To treat or not to treat

Warfarin or aspirin after mitral valve repair: Why work harder?

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

Severe tricuspid or mitral regurgitation in inoperable patients with aortic stenosis. Can we leave them alone? Juan A. Crestanello, MD The Journal of.

The future of cardiac surgery training: A survival guide

The patent internal thoracic artery graft: Increased degree of difficulty for left-sided pulmonary resections Robbin G. Cohen, MD, MMM The Journal of.

Surgical repair of congenital mitral valve malformations in infancy and childhood: A single-center 36-year experience Giovanni Stellin, MD, Massimo A.

Permanent pacemaker insertion following transcatheter aortic valve replacement: Not infrequent, not benign, and becoming predictable Craig M. Jarrett,

Tricuspid annulus diameter does not predict the development of tricuspid regurgitation after mitral valve repair for mitral regurgitation due to degenerative.

Reliability of risk algorithms in predicting early and late operative outcomes in high-risk patients undergoing aortic valve replacement Todd M. Dewey,

Alejandro R. Arevalo, MD, Umar S. Boston, MD, Steven P

After neoadjuvant chemoradiation therapy, predicted pulmonary function may be reduced by 10% Benny Weksler, MD, MBA The Journal of Thoracic and Cardiovascular.

“The more things change…”: The challenges ahead

Junaid Haroon, MD, Subroto Paul, MD, MPH

Ryan R. Davies, MD The Journal of Thoracic and Cardiovascular Surgery

Apples remain apples NO matter what

Preoperative PFTs: The answer is blowing in the wind

Current surgical therapy for Ebstein anomaly in neonates

Chordal replacement with polytetrafluoroethylene sutures for mitral valve repair: A 25- year experience Tirone E. David, MD, Susan Armstrong, MSc, Joan.

Which biologic valve should we select for the 45- to 65-year-old age group requiring aortic valve replacement? F. Dagenais, MD, P. Cartier, MD, P. Voisine,

What surgical improvements are needed to prove that anatomic repair is superior to physiologic repair in the majority of patients with corrected transposition.

Umar S. Boston, MD, Joseph A. Dearani, MD, Patrick W

Edward Y. Chan, MD, Michael J. Reardon, MD

Zone zero thoracic endovascular aortic repair is all about “location, location, location” Kevin L. Greason, MD The Journal of Thoracic and Cardiovascular.

Presentation transcript:

Complete repair of Ebstein anomaly in neonates and young infants: A 16-year follow-up Umar S. Boston, MD, Steven P. Goldberg, MD, Kent E. Ward, MD, Edward D. Overholt, MD, Thomas Spentzas, MD, MS, Thomas K. Chin, MD, Christopher J. Knott-Craig, MD The Journal of Thoracic and Cardiovascular Surgery Volume 141, Issue 5, Pages 1163-1169 (May 2011) DOI: 10.1016/j.jtcvs.2011.01.029 Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Kaplan–Meier survival estimate for all patients with Ebstein anomaly (n = 32). The Journal of Thoracic and Cardiovascular Surgery 2011 141, 1163-1169DOI: (10.1016/j.jtcvs.2011.01.029) Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 Survival after biventricular repair for Ebstein anomaly (n = 29). The Journal of Thoracic and Cardiovascular Surgery 2011 141, 1163-1169DOI: (10.1016/j.jtcvs.2011.01.029) Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions

Figure 3 Comparison of survival for neonates undergoing biventricular repair with (n = 11) and without (n = 10) anatomic pulmonary atresia (PA) (P = .03). The Journal of Thoracic and Cardiovascular Surgery 2011 141, 1163-1169DOI: (10.1016/j.jtcvs.2011.01.029) Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions

Figure 4 Severity of tricuspid valve regurgitation before repair and at late follow-up. Severity grades: 0 = none, 1 = mild, 2 = mild plus, 3 = moderate, and 4 = severe. The Journal of Thoracic and Cardiovascular Surgery 2011 141, 1163-1169DOI: (10.1016/j.jtcvs.2011.01.029) Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions

Figure 5 Freedom from reoperation for patients having biventricular repair (n = 29). The Journal of Thoracic and Cardiovascular Surgery 2011 141, 1163-1169DOI: (10.1016/j.jtcvs.2011.01.029) Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions

Figure 6 Surgical algorithm for symptomatic neonates with Ebstein anomaly. TR, Tricuspid regurgitation; PDA, patent ductus arteriosus; MPA, main pulmonary artery; SP, systemic–pulmonary. The Journal of Thoracic and Cardiovascular Surgery 2011 141, 1163-1169DOI: (10.1016/j.jtcvs.2011.01.029) Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions